The Discounted Cash Flow (DCF) valuation of Neuropace Inc (NPCE) is (12.83) USD. With the latest stock price at 15.61 USD, the upside of Neuropace Inc based on DCF is -182.2%.
Based on the latest price of 15.61 USD and our DCF valuation, Neuropace Inc (NPCE) is a sell. selling NPCE stocks now will result in a potential gain of 182.2%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.9% - 9.2% | 8.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (25.44) - (9.02) | (12.83) |
| Upside | -263.0% - -157.8% | -182.2% |